Koyfin Home > Directory > Health Care > Adma Biologics > EV / Sales (ntm)

Adma Biologics EV / Sales (ntm) Chart (ADMA)

Adma Biologics annual/quarterly EV / Sales (ntm) from 2013 to 2020.
  • Adma Biologics EV / Sales (ntm) for the quarter ending October 10, 2020 was 4.04 a -5.65% decrease of -0.23 year over year
  • Adma Biologics EV / Sales (ntm) for the last 12 months ending October 10, 2020 was 4.04 a -5.65% decrease of -0.23 year over year
  • Adma Biologics Annual EV / Sales (ntm) for 2020 was 4.04 a -1.61% decrease of -0.07 from 2019
  • Adma Biologics Annual EV / Sales (ntm) for 2020 was 4.10 a -1.19% decrease of -0.05 from 2019
  • Adma Biologics Annual EV / Sales (ntm) for 2020 was 4.15 a -2.75% decrease of -0.11 from 2019
Other Valuation Metrics:
  • Adma Biologics Market Cap for the quarter ending March 03, 2018 was $208m a 54.25% increase of 113m year over year
  • Adma Biologics Price / Book for the quarter ending March 03, 2018 was 5.17 a -360.96% decrease of -18.66 year over year
  • Adma Biologics Enterprise Value for the quarter ending March 03, 2018 was $206m a 49.35% increase of 101m year over year
View Chart On Koyfin

Quarterly ADMA EV / Sales (ntm) Data

10/20204.04
10/20204.10
10/20204.15
10/20204.27
10/20204.18
10/20204.38
10/20204.40
10/20204.51
10/20204.53
10/20204.62

Annual ADMA EV / Sales (ntm) Data

20204.04
20204.10
20204.15
20204.27
20204.18
20204.38
20204.40
20204.51
20204.53
20204.62